Agency
JPE
NF
Ph. Eur.
Quality Level
vapor pressure
<1.4 hPa ( 20 °C)
제품 라인
EMPROVE® ESSENTIAL
양식
viscous liquid
분자량
~1228
기술
API processing | nano-milling: suitable
refractive index
n20/D 1.468 (lit.)
pH
6-8 (20 °C, 50 g/L in H2O)
전이 온도
flash point 275 °C
density
1.095 g/mL at 25 °C (lit.)
응용 분야
liquid formulation
ophthalmics
pharma/biopharma processes
pharmaceutical
semi-solid formulation
solid formulation
solubility enhancement
저장 온도
15-25°C
SMILES string
CCCCCCCCCCCC(=O)OCCOCC(C1C(C(CO1)OCCO)OCCO)OCCO
InChI
1S/C26H50O10/c1-2-3-4-5-6-7-8-9-10-11-24(30)34-19-18-31-20-22(32-15-12-27)26-25(35-17-14-29)23(21-36-26)33-16-13-28/h22-23,25-29H,2-21H2,1H3
InChI key
HMFKFHLTUCJZJO-UHFFFAOYSA-N
유사한 제품을 찾으십니까? 방문 제품 비교 안내
1 of 4
이 품목 | 1.37172 | PHR3789 | 1547925 |
|---|---|---|---|
| application(s) liquid formulation | application(s) liquid formulation | application(s) pharmaceutical | application(s) pharmaceutical (small molecule) |
| technique(s) API processing | nano-milling: suitable | technique(s) - | technique(s) - | technique(s) - |
| agency JPE, Ph. Eur., NF | agency ChP, JPE, NF, Ph. Eur. | agency traceable to USP 1547925 | agency - |
| form viscous liquid | form liquid | form - | form - |
| product line EMPROVE® ESSENTIAL | product line EMPROVE® EXPERT | product line - | product line - |
| density 1.095 g/mL at 25 °C (lit.) | density 1.1 g/cm3 at 25 °C | density - | density - |
일반 설명
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
애플리케이션
법적 정보
used together
Storage Class Code
10 - Combustible liquids
WGK
WGK 1
Flash Point (°F)
527.0 °F - Pensky-Martens closed cup
Flash Point (°C)
275 °C - Pensky-Martens closed cup
Emprove® 프로그램을 사용하여 GMP 준수 유지
Emprove® Dossiers로 자격을 가속화하고, 규정 준수를 유지하며, 시간을 절약하세요.
주: EmproveSuite.com으로 이동하게 됩니다. 귀하의 사용자 이름과 비밀번호는 시그마알드리치닷컴과는 별개이며 다를 수 있습니다.
무료로 등록하고 몇 분 안에 Emprove® Dossiers에 액세스하세요. 구독 플랜을 업그레이드하여 Emprove® Suite에서 고급 및 맞춤형 콘텐츠를 잠금 해제하세요.
원하는 정보를 찾지 못하셨나요? Emprove® 프로그램 도움말 페이지 방문하기.
문서
Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.
관련 콘텐츠
Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.
Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.
활성 필터
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.
